Key result
IL1RN allele 2 carriage linked to ~2.2-fold higher odds of CAD in type 2 diabetes.
Observational (n=787)
Answers are grounded in this paper and cite their sources.
Recently, inflammation has received considerable attention in the pathogenesis of both type 2 diabetes and atherosclerosis. The interleukin-1 receptor antagonist (IL-1ra) is a major modulator of the interleukin-1 pro-inflammatory pathway. We studied the relationship between a variable number tandem repeat (VNTR) polymorphism in intron 2 of the IL-1ra gene (IL1RN) and coronary artery disease (CAD) in patients with and without type 2 diabetes, following 787 consecutive patients admitted for suspected CAD. According to the current criteria of the American Diabetes Association, 250 patients had type 2 diabetes. In this group of patients, allele 2 carriers (n = 108) had an increased prevalence of CAD compared with noncarriers (85.2 vs. 73.2%), a difference that remained significant in a multivariate logistic regression model (odds ratio 2.2, 95% CI 1.1-4.3, P = 0.02). No association of CAD with allele 2 carrier status was present among nondiabetic patients (n = 537). Enzyme-linked immunosorbent assays showed decreased baseline plasma levels of IL-1ra in patients with type 2 diabetes, which may in part explain the role of the IL1RN VNTR in these patients.
No takes yet. Share an insight, caveat, or question.
Marculescu et al. (2002) conducted an observational in Suspected coronary artery disease and type 2 diabetes (n=787). IL1RN VNTR allele 2 carrier status vs. Noncarriers was evaluated on Prevalence of coronary artery disease (CAD) (OR 2.2, 95% CI 1.1-4.3, p=0.02). In patients with type 2 diabetes, being an IL1RN allele 2 carrier was associated with a increased prevalence of coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: